NEW DELHI, Chikumi 22 (Xinhua) — Bharat Biotech's covaxin, kambani inogadzira majekiseni muIndia, yakaratidza kushanda zvakanaka kwe77.8 muzana mukuyedzwa kwechikamu chechitatu, sezvakataurwa nevezvenhau vakawanda vemuno neChipiri.
"Covaxin yeBharat Biotech inoshanda ne77.8 muzana mukudzivirira COVID-19, zvichienderana nedata kubva mumiedzo yechikamu chechitatu yakaitwa pavanhu 25,800 muIndia yese," akadaro mushumo.
Mwero wekushanda zvakanaka kwemushonga uyu wakabuda neChipiri mushure mekunge komiti yenyanzvi dzemishonga (SEC) yeDrugs Controller General of India (DCGI) yasangana ndokukurukura zvakabuda.
Kambani yemishonga yakaendesa ruzivo rwechikamu chechitatu chekuedza mushonga wekudzivirira kuDCGI pakupera kwevhiki.
Mishumo yakati kambani iyi inotarisirwa kuita musangano wekuti "zvisati zvatumirwa" nevakuru veWorld Health Organisation neChitatu, kuti vakurukure gwara rekutumira kwekupedzisira ruzivo nemagwaro zvinodiwa.
India yakatanga kubaiwa nhomba yeCOVID-19 nevanhu vakawanda musi wa16 Ndira nekupa nhomba mbiri dzakagadzirwa muIndia, dzinoti Covishield neCovaxin.
Sangano reSerum Institute of India (SII) riri kugadzira Covishield yeAstraZeneca-Oxford University, ukuwo Bharat Biotech yakabatana neIndian Council of Medical Research (ICMR) mukugadzira Covaxin.
Mushonga weSputnik V wakagadzirwa kuRussia wakatangwawo munyika iyi.
Nguva yekutumira: Chikumi-25-2021